Sarabia, Erica Zia E.
HRN: 24-60-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2025
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
05/19/2025
05/26/2025
PO
3ml
Q 12
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes